Medical/Pharmaceuticals
SyntheticMR and Philips Announce Expanded Global Partnership for SyMRI 3D
LINKÖPING, Sweden, Nov. 30, 2023 /PRNewswire/ -- SyntheticMR announced today that they have expanded their partnership with Philips to include SyMRI 3D. The expanded agreement between Philips and SyntheticMR means that SyMRI 3D will be included in Philips' global price book once the relevant reg...
Triple Negative Breast Cancer: Expert Consensus on Local Treatment Options
Hong Kong Breast Cancer Foundation Launches "Immunotherapy Drug Financial Assistance Programme" to Benefit Patients in Need HONG KONG, Nov. 30, 2023 /PRNewswire/ -- Breast cancer is the leading cancer facing women inHong Kong. According to the statistics released by the Hong Kong Cancer Registry...
Philips Future Health Index 2023 Report: Singapore's healthcare sector at the forefront of digital technology adoption to tackle staff shortages and improve efficiency
* 75% of healthcare leaders (vs 56% globally) in Singapore are already using, or planning to use, digital health technology to reduce the impact of healthcare workforce shortages. * A hospital/facility being at the forefront of AI is an important consideration by younger healthcare profession...
Awareness, Accessibility, and Affordability are Crucial for the Early Detection of Thalassemia
- Dr. Zhiyu Peng, Deputy GM at BGI Genomics, Head of the World Hemoglobinopathy Foundation, and Dr.Androulla Eleftheriou, Executive Director at TIF, analyze findings from the Global 2023 State of Thalassemia Awareness Report BANGKOK, Nov. 30, 2023 /PRNewswire/ -- Thalassemia, a hereditary hemogl...
Everest Medicines Announces Acceptance of Nefecon® New Drug Applications for the Treatment of Primary IgA Nephropathy in Adult Patients in South Korea
SHANGHAI, Nov. 30, 2023 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative medicines and vaccines, announced today that its New Drug Application (NDA) for Nefecon®...
ShiraTronics Announces Groundbreaking Milestone: World's First Trial Phase Procedures for their Chronic Migraine Therapy System in Australian Pilot Study
MINNEAPOLIS, Nov. 30, 2023 /PRNewswire/ -- ShiraTronics, Inc., a pioneering medical device company, today announced the initiation of its groundbreaking RELIEV-CM pilot study inAustralia, marking the world's first seven patients' successful completion of trial phase procedures for their Chronic M...
Phase II OPALESCENCE Study of TLX250-CDx in Triple Negative Breast Cancer to be Presented at SABCS
MELBOURNE, Australia, Nov. 30, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today advises that the completed Phase II OPALESCENCE investigator-initiated trial (IIT) of its carbonic anhydrase IX (CAIX)-targeting positron emission tomography (PET) imaging candid...
Unither Pharmaceuticals celebrates 30 years of innovation and expertise
PARIS, Nov. 30, 2023 /PRNewswire/ -- Unither Pharmaceuticals, a leading CDMO (Contract Development and Manufacturing Organization), celebrates 30 years in business. In 1993, Unither Pharmaceuticals began operations by acquiring a 17-man pharmaceutical plant that produced 3 pharmaceutical forms. T...
Bahrain, First in the Middle East to Acquire Latest Machine used for Human Genome Sequencing
MANAMA, Bahrain, Nov. 29, 2023 /PRNewswire/ -- The Ministry of Health in the Kingdom ofBahrain has become the first in the Middle East to acquire and inaugurate the use of the cutting-edge NovaSeqTM X Plus machine for human genome sequencing purposes. The move is part of the Kingdom's commitment ...
Ping An Health Wins Good Design Award for Its Innovative Design
SHANGHAI, Nov. 29, 2023 /PRNewswire/ -- Ping An Health was recently honored with
Japan's Good Design Award, commonly known as the "The oriental Oscar Award of
Design", for its outstanding innovation design and user-friendly design.
GILEAD SCIENCES AWARDS OVER US$1.5 MILLION TO STRENGTHEN SUPPORT FOR COMMUNITY-LED HIV PROJECTS IN ASIA PACIFIC
–2023 Gilead Asia Pacific Rainbow Grant Funding Will Support 40 Projects In 2024-2025 To Reduce HIV Stigma And Improve Equity Across Asia Pacific – – Since 2018, The Gilead Asia Pacific Rainbow Grant Has Awarded Close To US$6 Million To 144 Community-Based Projects In The Region, Supporting 130 00...
"Anti-Choke Mug" - Chula Innovation for Neuro Patients to Drink Water Confidently
BANGKOK, Nov. 29, 2023 /PRNewswire/ -- Chula
VISTA Eye Specialist Unveils Innovative Solution for Reading Problems
PETALING JAYA, Malaysia, Nov. 29, 2023 /PRNewswire/ -- VISTA Eye Specialist (VISTA) proudly introduces the groundbreaking EVO Viva Implantable Collamer Lens (Viva) to address the dual challenge of short-sightedness and reading problems (presbyopia) among patients aged above 40. This cutting-edge ...
Kailo Medical Presents: KailoFlow - Elevating the Generative Reporting Experience to the Web
CHICAGO, Nov. 29, 2023 /PRNewswire/ -- Kailo Medical, a recognized leader in medical software and services, proudly announces the launch ofKailoFlow, the web-based evolution of the premier structured reporting platform,SonoReview. Marrying progress, innovation, and accessibility, KailoFlow is the...
Novavax's Updated Protein-based COVID-19 Vaccine Now an Option for All 194 Member States of the World Health Organization
GAITHERSBURG, Md., Nov. 28, 2023 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced that Nuvaxovid™ XBB.1.5 COVID-19 Vaccine (NVX-CoV2601) has been granted Emergency Use Listing (EUL) by the World Health Or...
JOGO HEALTH (INDIA) GRANTED WORLD'S FIRST JOINT COMMISSION INTERNATIONAL(JCI) ACCREDITATION FOR A DIGITAL CLINIC
* Chicago based Joint Commission helps healthcare organizations improve clinical and operational processes and build staff competencies and knowledge of leading practices. * More than 22,000 US health care organizations are accredited by Joint Commission and a majority of US state government...
RemeGen Announces Publication of Results from Two Phase II Studies for Disitamab Vedotin in Latest Issue of Journal of Clinical Oncology (JCO)
YANTAI, China, Nov. 28, 2023 /PRNewswire/ -- RemeGen Co. Ltd.
Daewoong Pharmaceutical Received GMP Certification from Brazilian ANVISA
SEOUL, South Korea, Nov. 28, 2023 /PRNewswire/ -- Daewoong Pharmaceutical is pleased to announce that its Osong factory in Korea achieved Good Manufacturing Practice (GMP) certification from the Regulatory Authority ofBrazil, ANVISA. Daewoong Pharmaceutical, represented by CEO Seng-ho Jeon and ...
XtalPi and HKU's Advanced Biomedical Instrumentation Centre Sign MoU to Accelerate Deep Tech Commercialization
CAMBRIDGE, Mass., Nov. 27, 2023 /PRNewswire/ -- XtalPi Inc. (XtalPi) and the Advanced Biomedical Instrumentation Centre (ABIC or the Centre) at the University of Hong Kong (HKU) have entered a memorandum of understanding (MoU) that outlines a roadmap for scientific collaboration and commercializat...
"Anti-Choke Mug" - Chula Innovation for Neuro Patients to Drink Water Confidently
BANGKOK, Thailand, Nov. 27, 2023 /PRNewswire/ -- Chula
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 313 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00